The smoker's paradox and the real risk of smoking
- PMID: 15792283
- DOI: 10.1007/s10654-004-3004-x
The smoker's paradox and the real risk of smoking
Abstract
No satisfactory explanations have been offered for the smoker's paradox, the greater short-term survival of smokers after a myocardial infarction nor for the large variations in the coronary risk rate for smoking ranging between 1 and 5.9. These discrepancies as well as the smoker's paradox may be caused by different baseline characteristics of smokers and nonsmokers, whereas the usually quoted coronary risk of 2 is derived from studies based on the assumption of equal baseline characteristics. As neither this assumption nor the possibility of unequal starting conditions have been tested, we examined the main cardiovascular risk factors in smoking and nonsmoking boys as near as possible to baseline, at the age of fourteen. This age appeared to be best suited, because boys starting to smoke early are most likely to become regular and heavy smokers. Of 336 boys, 39 had smoked 8.3+/-6.0 cigarettes/day for 15.5+/-11.2 months. Compared to nonsmokers, boys who started to smoke early had lower LDL cholesterol and alpha2-antiplasmin, greater handgrip strength, vital capacity and forced expiratory volume, better perfomance on bicycle ergometry and higher testosterone. The differences in total cholesterol, LDL cholesterol, vital capacity, handgrip strength, testosterone and alpha2-antiplasmin persisted after adjustment for age, body mass, and testosterone. In addition, the differences in perfomance on bicycle ergometry and forced expiratory volume persisted after adjustment for age. These favourable baseline characteristics of those starting to smoke early can explain the smoker's paradox. In addition, they suggest that the individual coronary risk in smokers is considerably higher than 2, because the assumption of equal baseline characteristics of smokers and nonsmokers cannot be upheld.
Similar articles
-
Smoker's Paradox in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.J Am Heart Assoc. 2016 Apr 22;5(4):e003370. doi: 10.1161/JAHA.116.003370. J Am Heart Assoc. 2016. PMID: 27107131 Free PMC article.
-
Change in left ventricular systolic function in patients with ST elevation myocardial infarction: Evidence for smoker's paradox or pseudo-paradox?Indian Heart J. 2016 Nov-Dec;68(6):816-820. doi: 10.1016/j.ihj.2016.04.001. Epub 2016 Apr 14. Indian Heart J. 2016. PMID: 27931553 Free PMC article.
-
Absence of a 'smoker's paradox' in field triaged ST-elevation myocardial infarction patients undergoing percutaneous coronary intervention.Cardiovasc Revasc Med. 2013 Jul-Aug;14(4):213-7. doi: 10.1016/j.carrev.2013.06.002. Epub 2013 Jul 13. Cardiovasc Revasc Med. 2013. PMID: 23856073
-
Investigation of smoking on the antiplatelet response to clopidogrel: Unravelling the smoker's paradox.Pathol Res Pract. 2024 May;257:155290. doi: 10.1016/j.prp.2024.155290. Epub 2024 Apr 10. Pathol Res Pract. 2024. PMID: 38640781 Review.
-
Thienopyridine efficacy and cigarette smoking status.Am Heart J. 2013 May;165(5):693-703. doi: 10.1016/j.ahj.2012.12.024. Epub 2013 Mar 26. Am Heart J. 2013. PMID: 23622905 Review.
Cited by
-
"Smoker's paradox" in in-hospital outcomes of left ventricular assist device implantation: a population-based analysis of National Inpatient Sample from 2015-2021.J Artif Organs. 2025 May 26. doi: 10.1007/s10047-025-01515-w. Online ahead of print. J Artif Organs. 2025. PMID: 40419742
-
Baseline factors identified for the prediction of good responders in patients with end-stage diffuse coronary artery disease undergoing intracoronary CD34+ cell therapy.Stem Cell Res Ther. 2020 Jul 29;11(1):324. doi: 10.1186/s13287-020-01835-z. Stem Cell Res Ther. 2020. PMID: 32727585 Free PMC article.
-
Lifetime cigarette smoking and breast cancer prognosis in the After Breast Cancer Pooling Project.J Natl Cancer Inst. 2014 Jan;106(1):djt359. doi: 10.1093/jnci/djt359. Epub 2013 Dec 7. J Natl Cancer Inst. 2014. PMID: 24317179 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials